Title : Nilotinib in the treatment of chronic myeloid leukemia.

Pub. Date : 2019 Mar

PMID : 30547682






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Nilotinib, a second-generation tyrosine kinase inhibitor, was designed to overcome resistance of a wide range of BCR-ABL mutants to imatinib. nilotinib ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens